This invention relates to CCK-A agonists of Formula (I) ##STR00001## wherein R.sup.1-R.sup.4, A, B, X, D, E and G are as defined in the specification, as well as, among other things, pharmaceutical compositions containing the compounds and methods of use of the compounds and compositions. The compounds are useful in treating diabetes.

 
Web www.patentalert.com

< Methods for detecting, prognosing, or monitoring a disorder by comparing relative flux rates of two or more biological molecules in vivo

> Substituted amino carboxylic acids
~ 00426